For more than a year, Lonza has been working behind the scenes to manufacture Moderna's vaccine.
Unknown to the general public, the Swiss industrialist, the world's leading producer of active ingredients for the pharmaceutical industry, suddenly found himself in the spotlight.
It is he who manufactures the messenger RNA of the famous serum in three of his six factories (Portsmouth, in the United States, Visp, in Switzerland, and Geleen, in the Netherlands) and delivers it in the form of frozen liquid to the others. Moderna's subcontractors.
In Europe, Rovi (Spain) and Recipharm (France) are responsible for bottling it.
Read also
Covid-19 is accelerating the transformation of French pharmacies
The partnership between Moderna and Lonza dates back to May 2020, when American biotech had almost no orders.
In 2021, Lonza had to increase its production capacities
"in record time",
comments its CEO, Pierre-Alain Ruffieux, to support the rise in volumes of Moderna: the American biotech produced 807 million Covid vaccines and plans…
This article is for subscribers only.
You have 68% left to discover.
Cultivating your freedom is cultivating your curiosity.
Keep reading your article for 1€ the first month
I ENJOY IT
Already subscribed?
Login